Angelica Sette
About
In The Last Decade
Angelica Sette
8 papers receiving 334 citations
Peers
Comparison fields: 5 of 60
- Immunology 167
- Molecular Biology 145
- Epidemiology 111
- Physiology 84
- Oncology 57
Countries citing papers authored by Angelica Sette
This map shows the geographic impact of Angelica Sette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelica Sette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelica Sette more than expected).
Fields of papers citing papers by Angelica Sette
This network shows the impact of papers produced by Angelica Sette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelica Sette. The network helps show where Angelica Sette may publish in the future.
Co-authorship network of co-authors of Angelica Sette
This figure shows the co-authorship network connecting the top 25 collaborators of Angelica Sette. A scholar is included among the top collaborators of Angelica Sette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelica Sette. Angelica Sette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 33 | |
| 3 | 83 | |
| 4 | 15 | |
| 5 | 6 | |
| 6 | 14 | |
| 7 | Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. | 155 |
| 8 | Synthetic antigenic peptides as a new strategy for immunotherapy of cancer. | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.